K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder
SUMMARY The human fibroblast growth factor receptor 3 (FGFR3) gene is frequently mutated in superficial urothelial cell carcinoma (UCC). To test the functional significance of FGFR3 activating mutations as a ‘driver’ of UCC, we targeted the expression of mutated Fgfr3 to the murine urothelium using...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2011-07-01
|
Series: | Disease Models & Mechanisms |
Online Access: | http://dmm.biologists.org/content/4/4/548 |
id |
doaj-4cb9c5d92474456da4eabdd48f5bb905 |
---|---|
record_format |
Article |
spelling |
doaj-4cb9c5d92474456da4eabdd48f5bb9052020-11-25T00:11:42ZengThe Company of BiologistsDisease Models & Mechanisms1754-84031754-84112011-07-014454855510.1242/dmm.006874006874K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladderImran AhmadLukram Babloo SinghMona FothCarol-Ann MorrisMakoto Mark TaketoXue-Ru WuHing Y. LeungOwen J. SansomTomoko IwataSUMMARY The human fibroblast growth factor receptor 3 (FGFR3) gene is frequently mutated in superficial urothelial cell carcinoma (UCC). To test the functional significance of FGFR3 activating mutations as a ‘driver’ of UCC, we targeted the expression of mutated Fgfr3 to the murine urothelium using Cre-loxP recombination driven by the uroplakin II promoter. The introduction of the Fgfr3 mutations resulted in no obvious effect on tumorigenesis up to 18 months of age. Furthermore, even when the Fgfr3 mutations were introduced together with K-Ras or β-catenin (Ctnnb1) activating mutations, no urothelial dysplasia or UCC was observed. Interestingly, however, owing to a sporadic ectopic Cre recombinase expression in the skin and lung of these mice, Fgfr3 mutation caused papilloma and promoted lung tumorigenesis in cooperation with K-Ras and β-catenin activation, respectively. These results indicate that activation of FGFR3 can cooperate with other mutations to drive tumorigenesis in a context-dependent manner, and support the hypothesis that activation of FGFR3 signaling contributes to human cancer.http://dmm.biologists.org/content/4/4/548 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Imran Ahmad Lukram Babloo Singh Mona Foth Carol-Ann Morris Makoto Mark Taketo Xue-Ru Wu Hing Y. Leung Owen J. Sansom Tomoko Iwata |
spellingShingle |
Imran Ahmad Lukram Babloo Singh Mona Foth Carol-Ann Morris Makoto Mark Taketo Xue-Ru Wu Hing Y. Leung Owen J. Sansom Tomoko Iwata K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder Disease Models & Mechanisms |
author_facet |
Imran Ahmad Lukram Babloo Singh Mona Foth Carol-Ann Morris Makoto Mark Taketo Xue-Ru Wu Hing Y. Leung Owen J. Sansom Tomoko Iwata |
author_sort |
Imran Ahmad |
title |
K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder |
title_short |
K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder |
title_full |
K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder |
title_fullStr |
K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder |
title_full_unstemmed |
K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder |
title_sort |
k-ras and β-catenin mutations cooperate with fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder |
publisher |
The Company of Biologists |
series |
Disease Models & Mechanisms |
issn |
1754-8403 1754-8411 |
publishDate |
2011-07-01 |
description |
SUMMARY
The human fibroblast growth factor receptor 3 (FGFR3) gene is frequently mutated in superficial urothelial cell carcinoma (UCC). To test the functional significance of FGFR3 activating mutations as a ‘driver’ of UCC, we targeted the expression of mutated Fgfr3 to the murine urothelium using Cre-loxP recombination driven by the uroplakin II promoter. The introduction of the Fgfr3 mutations resulted in no obvious effect on tumorigenesis up to 18 months of age. Furthermore, even when the Fgfr3 mutations were introduced together with K-Ras or β-catenin (Ctnnb1) activating mutations, no urothelial dysplasia or UCC was observed. Interestingly, however, owing to a sporadic ectopic Cre recombinase expression in the skin and lung of these mice, Fgfr3 mutation caused papilloma and promoted lung tumorigenesis in cooperation with K-Ras and β-catenin activation, respectively. These results indicate that activation of FGFR3 can cooperate with other mutations to drive tumorigenesis in a context-dependent manner, and support the hypothesis that activation of FGFR3 signaling contributes to human cancer. |
url |
http://dmm.biologists.org/content/4/4/548 |
work_keys_str_mv |
AT imranahmad krasandbcateninmutationscooperatewithfgfr3mutationsinmicetopromotetumorigenesisintheskinandlungbutnotinthebladder AT lukrambabloosingh krasandbcateninmutationscooperatewithfgfr3mutationsinmicetopromotetumorigenesisintheskinandlungbutnotinthebladder AT monafoth krasandbcateninmutationscooperatewithfgfr3mutationsinmicetopromotetumorigenesisintheskinandlungbutnotinthebladder AT carolannmorris krasandbcateninmutationscooperatewithfgfr3mutationsinmicetopromotetumorigenesisintheskinandlungbutnotinthebladder AT makotomarktaketo krasandbcateninmutationscooperatewithfgfr3mutationsinmicetopromotetumorigenesisintheskinandlungbutnotinthebladder AT xueruwu krasandbcateninmutationscooperatewithfgfr3mutationsinmicetopromotetumorigenesisintheskinandlungbutnotinthebladder AT hingyleung krasandbcateninmutationscooperatewithfgfr3mutationsinmicetopromotetumorigenesisintheskinandlungbutnotinthebladder AT owenjsansom krasandbcateninmutationscooperatewithfgfr3mutationsinmicetopromotetumorigenesisintheskinandlungbutnotinthebladder AT tomokoiwata krasandbcateninmutationscooperatewithfgfr3mutationsinmicetopromotetumorigenesisintheskinandlungbutnotinthebladder |
_version_ |
1725402677079179264 |